GlassScriptPhysician profile
David A Daniels
NPI 1215916838
$735.28
in general payments reported to CMS, 2019-2025
15 companies · $48.56 in 2025
The $48.56 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $60.80 · 2021: $41.89 · 2022: $173 · 2023: $59.30 · 2024: $145 · 2025: $48.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $185.04 | 2021-2025 | Dalvance |
| Kci USA, INC. | $92.71 | 2019-2022 | |
| Smith+Nephew, INC. | $87.42 | 2019-2022 | |
| Allergan, INC. | $71.42 | 2019-2020 | |
| Organogenesis INC. | $70.85 | 2022-2024 | Puraply |
| Kerecis Limited | $50.56 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Aroa Biosurgery Incorporated | $49.56 | 2022-2024 | |
| Convatec INC. | $22.81 | 2023 | |
| Arteriocyte Medical Systems, INC. | $20.36 | 2019 | |
| Integra Lifesciences Corporation | $17.89 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.29 | 2019 | |
| Mckesson Patient Care Solutions INC. | $14.48 | 2019 | |
| Medline Industries LP | $12.11 | 2019 | |
| Tactile Systems Technology INC | $11.54 | 2021 | |
| Merck Sharp & Dohme LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.